Ginkgo Bioworks Holdings annual net debt
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Net Debt Growth & History (DNA)
Ginkgo Bioworks Holdings's net debt was $272.7M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $272.7M | $366.5M | — |
| 2024 | 2024-12-31 | −$93.8M | $608.0M | — |
| 2023 | 2023-12-31 | −$701.8M | $169.9M | — |
| 2022 | 2022-12-31 | −$871.7M | $656.0M | — |
| 2021 | 2021-12-31 | −$1.53B | −$1.16B | — |
| 2020 | 2020-12-31 | −$364.3M | — | — |
Ginkgo Bioworks Holdings quarterly net debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $319.6M | $94.3M | +41.87% |
| Q1 2026 | 2026-03-31 | $266.8M | $144.7M | +118.47% |
| Q4 2025 | 2025-12-31 | $272.7M | $366.5M | — |
| Q3 2025 | 2025-09-30 | $311.8M | $482.4M | — |
| Q2 2025 | 2025-06-30 | $225.3M | $503.4M | — |
| Q1 2025 | 2025-03-31 | $122.1M | $728.1M | — |
| Q4 2024 | 2024-12-31 | −$93.8M | $608.0M | — |
| Q3 2024 | 2024-09-30 | −$170.6M | $475.0M | — |
| Q2 2024 | 2024-06-30 | −$278.1M | $416.7M | — |
| Q1 2024 | 2024-03-31 | −$605.9M | $196.0M | — |
| Q4 2023 | 2023-12-31 | −$701.8M | $169.9M | — |
| Q3 2023 | 2023-09-30 | −$645.6M | $597.2M | — |
| Q2 2023 | 2023-06-30 | −$694.8M | $630.8M | — |
| Q1 2023 | 2023-03-31 | −$802.0M | $663.7M | — |
| Q4 2022 | 2022-12-31 | −$871.7M | $656.0M | — |
| Q3 2022 | 2022-09-30 | −$1.24B | $480.0M | — |
| Q2 2022 | 2022-06-30 | −$1.33B | — | — |
| Q1 2022 | 2022-03-31 | −$1.47B | — | — |
| Q4 2021 | 2021-12-31 | −$1.53B | −$1.54B | — |
| Q3 2021 | 2021-09-30 | −$1.72B | — | — |
| Q4 2020 | 2020-12-31 | $16.5M | — | — |
Ginkgo Bioworks Holdings net debt trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's net debt increased from −$364.3M to $272.7M, a change of $637.0M. The latest reported quarter, Q2 2026, shows $319.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...